{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:28:29Z","timestamp":1787689709512,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.diabres.2021.108926","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T17:57:44Z","timestamp":1624211864000},"page":"108926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Relationship between intact parathyroid hormone and all-cause death, cardiovascular events, and ectopic calcification in patients with diabetic kidney disease: A retrospective study"],"prefix":"10.1016","volume":"177","author":[{"given":"Mengyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108926_b0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41581-020-00367-2","article-title":"Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence","volume":"17","author":"Alicic","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2021.108926_b0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-021-05444-0","article-title":"Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease","author":"Chan","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108926_b0015","first-page":"751","article-title":"Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention","volume":"99","author":"McGrath","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.diabres.2021.108926_b0020","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1097\/01.ASN.0000019641.41496.1E","article-title":"Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study","volume":"13","author":"Longenecker","year":"2002","journal-title":"J of the Am Soc of Nephrology : JASN."},{"key":"10.1016\/j.diabres.2021.108926_b0025","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108926_b0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ckj\/sfv073","article-title":"Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease","volume":"8","author":"Di Lullo","year":"2015","journal-title":"Clinical kidney journal."},{"key":"10.1016\/j.diabres.2021.108926_b0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2016.08.004","article-title":"Predictors of abdominal aortic calcification progression in patients with chronic kidney disease without hemodialysis","volume":"253","author":"Yamamoto","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.diabres.2021.108926_b0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.06620617","article-title":"Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease","volume":"13","author":"Seiler-Mussler","year":"2018","journal-title":"Clinical journal of the American Society of Nephrology : CJASN."},{"key":"10.1016\/j.diabres.2021.108926_b0045","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2215\/CJN.05390518","article-title":"PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT","volume":"13","author":"Ginsberg","year":"2018","journal-title":"Clinical journal of the American Society of Nephrology : CJASN."},{"key":"10.1016\/j.diabres.2021.108926_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016528","article-title":"Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3","volume":"7","author":"Shardlow","year":"2017","journal-title":"BMJ open."},{"key":"10.1016\/j.diabres.2021.108926_b0055","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstr\u00f6m","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108926_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820958322","article-title":"Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism","volume":"11","author":"Yu","year":"2020","journal-title":"Therapeutic advances in endocrinology and metabolism."},{"key":"10.1016\/j.diabres.2021.108926_b0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4103\/jfmpc.jfmpc_174_17","article-title":"Association of Vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney disease","volume":"7","author":"Sonkar","year":"2018","journal-title":"Journal of family medicine and primary care."},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2021.108926_b0070","doi-asserted-by":"crossref","first-page":"S931","DOI":"10.1016\/j.dsx.2017.07.019","article-title":"Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study","volume":"11","author":"Ray","year":"2017","journal-title":"Diabetes Metab Syndr."},{"key":"10.1016\/j.diabres.2021.108926_b0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ndt\/gfr447","article-title":"Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system","volume":"27","author":"Cust\u00f3dio","year":"2012","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schl\u00fcter","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.diabres.2021.108926_b0085","first-page":"2","article-title":"Diagnosis of diabetic kidney disease: state of the art and future perspective","volume":"2018","author":"Persson","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.diabres.2021.108926_b0090","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1681\/ASN.2018121231","article-title":"Effects of Selonsertib in Patients with Diabetic Kidney Disease","volume":"30","author":"Chertow","year":"2019","journal-title":"Journal of the American Society of Nephrology : JASN."},{"key":"10.1016\/j.diabres.2021.108926_b0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cca.2018.07.045","article-title":"Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia","volume":"486","author":"Li","year":"2018","journal-title":"Clinica chimica acta; international journal of clinical chemistry."},{"key":"10.1016\/j.diabres.2021.108926_b0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/ki.2010.462","article-title":"Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities","volume":"79","author":"Stevens","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2021.108926_b0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.diabres.2021.108926_b0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"Lishmanov","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.diabres.2021.108926_b0115","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","article-title":"Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP)","volume":"53","author":"Bhuriya","year":"2009","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation."},{"key":"10.1016\/j.diabres.2021.108926_b0120","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00198-019-05033-3","article-title":"Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease","volume":"30","author":"Geng","year":"2019","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.diabres.2021.108926_b0125","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfz060","article-title":"Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort","volume":"35","author":"Lamina","year":"2020","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0135","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108926_b0140","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/gfq582","article-title":"Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients","volume":"26","author":"Noordzij","year":"2011","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0145","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1080\/03007995.2018.1467886","article-title":"Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study","volume":"34","author":"Liu","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2021.108926_b0150","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/ndt\/gfl291","article-title":"The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients","volume":"21","author":"Tomiyama","year":"2006","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jim-2018-000852","article-title":"Fractional excretion of phosphorus and vascular calcification in stage 3 chronic kidney disease","volume":"67","author":"Jim\u00e9nez Villodres","year":"2019","journal-title":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research."},{"key":"10.1016\/j.diabres.2021.108926_b0160","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ndt\/gfm639","article-title":"Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy","volume":"23","author":"Murakami","year":"2008","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/8756-3282(92)90201-7","article-title":"Bone mass status in different degrees of chronic renal failure","volume":"13","author":"Bianchi","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.diabres.2021.108926_b0175","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s00198-016-3636-1","article-title":"Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients","volume":"27","author":"Lee","year":"2016","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.diabres.2021.108926_b0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA cardiology."},{"key":"10.1016\/j.diabres.2021.108926_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40620-015-0260-7","article-title":"Abdominal aortic calcification in patients with CKD","volume":"30","author":"Peeters","year":"2017","journal-title":"Journal of nephrology."},{"key":"10.1016\/j.diabres.2021.108926_b0190","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"The New England journal of medicine."},{"key":"10.1016\/j.diabres.2021.108926_b0195","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2796.2007.01778.x","article-title":"Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women","volume":"261","author":"Snijder","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.diabres.2021.108926_b0205","doi-asserted-by":"crossref","unstructured":"Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedg\u00e5rd P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery. 2002;132:1126-32; discussion 32.","DOI":"10.1067\/msy.2002.128692"},{"key":"10.1016\/j.diabres.2021.108926_b0210","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/ndt\/gfm269","article-title":"Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways","volume":"22","author":"Rashid","year":"2007","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association."},{"key":"10.1016\/j.diabres.2021.108926_b0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000069761","article-title":"Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells","volume":"26","author":"Perkovic","year":"2003","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.diabres.2021.108926_b0220","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","article-title":"Vascular calcification: contribution of parathyroid hormone in renal failure","volume":"71","author":"Neves","year":"2007","journal-title":"Kidney Int."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:20:54Z","timestamp":1759173654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":44,"alternative-id":["S0168822721002862"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108926","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between intact parathyroid hormone and all-cause death, cardiovascular events, and ectopic calcification in patients with diabetic kidney disease: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108926"}}